Geron Corp.
(NASDAQ : GERN)

( )
GERN PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 0.82%132.300.0%$1592.67m
OCGNOcugen, Inc. -14.25%8.970.0%$993.97m
NVAXNovavax, Inc. -13.89%158.1092.9%$973.00m
AMGNAmgen, Inc. -0.91%221.911.3%$586.84m
REGNRegeneron Pharmaceuticals, Inc. 0.59%449.382.7%$521.53m
VRTXVertex Pharmaceuticals, Inc. -0.31%207.791.9%$503.86m
GILDGilead Sciences, Inc. 0.77%63.231.0%$499.99m
ILMNIllumina, Inc. -4.03%399.613.5%$482.11m
BIIBBiogen, Inc. -1.14%263.571.7%$367.21m
ALXNAlexion Pharmaceuticals, Inc. 0.18%148.462.0%$360.83m
CRSPCRISPR Therapeutics AG -3.02%115.490.6%$268.32m
BNGOBioNano Genomics, Inc. -19.30%6.900.0%$265.49m
EXASEXACT Sciences Corp. -4.39%121.0218.4%$224.11m
SGENSeagen Inc. -1.68%145.455.8%$204.38m
VXRTVaxart, Inc. -6.92%5.920.0%$174.35m

Company Profile

Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Menlo Park, CA.